{"id":3913,"date":"2026-05-25T09:13:56","date_gmt":"2026-05-25T06:13:56","guid":{"rendered":"http:\/\/sw-themes.com\/porto_dummy\/?post_type=event&#038;p=3913"},"modified":"2026-06-22T12:21:00","modified_gmt":"2026-06-22T09:21:00","slug":"class-3-drug-device-combinations","status":"publish","type":"event","link":"https:\/\/demo.erayonetim.com\/en\/hizmetlerimiz\/sinif-3-ilacli-tibbi-cihazlar\/","title":{"rendered":"Class III Medical Devices"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><section class=\"vc_section service-page-section vc_custom_1000000\"><div class=\"vc_row wpb_row top-row porto-inner-container wpb_custom_034b39d9bc6c6b310d69e39f0ccf274f\"><div class=\"porto-wrap-container container\"><div class=\"row\"><div class=\"vc_column_container col-md-12\"><div class=\"wpb_wrapper vc_column-inner\"><div class=\"vc_row wpb_row vc_inner row vc_custom_1000004\"><div class=\"vc_column_container col-md-12\"><div class=\"wpb_wrapper vc_column-inner\">\r\n\t<div class=\"wpb_text_column wpb_content_element wpb_custom_7c91d232724f73626cc933bd95b25ff0\" >\r\n\t\t<div class=\"wpb_wrapper\">\r\n\t\t\t<h4 style=\"font-size: 32px; font-weight: 800; color: #0c3261; margin-top: 10px; margin-bottom: 20px; font-family: 'Poppins', sans-serif; line-height: 1.3;\">\ud83d\udcc2 Class III Pharmaceutical Devices and DMF Consulting<\/h4>\n<h4 style=\"font-size: 26px; font-weight: 800; color: #0c3261; margin-top: 0px; margin-bottom: 20px; font-family: 'Poppins', sans-serif; line-height: 1.3;\">\u0130la\u00e7 \u0130\u00e7eren T\u0131bbi Cihazlar\u0131n\u0131z \u0130\u00e7in Reg\u00fclasyon ve Dosya Haz\u0131rl\u0131k Deste\u011fi (MDR Ek VIII, Kural 14 &#038; Madde 117)<\/h4>\n<div style=\"background: #f8f9fa; padding: 20px; border-radius: 12px; border: 1px solid #e1e1e1; margin-bottom: 20px;\">\n<h5 style=\"color: #0c3261; margin-top: 0;\">\ud83d\udccc Quick Facts Box:<\/h5>\n<ul style=\"list-style: none; padding-left: 0; font-size: 15px; color: #444444;\">\n<li style=\"margin-bottom: 5px;\">\ud83d\udd39 Does your device contain a medication that has a systemic effect?<\/li>\n<li style=\"margin-bottom: 5px;\">\ud83d\udd39 Is the pharmaceutical substance an integral part of the device?<\/li>\n<li style=\"margin-bottom: 0;\">\ud83d\udd39 Is a consultation procedure required from the competent authority during the approval process?<\/li>\n<\/ul>\n<\/div>\n<p style=\"font-size: 16px; color: #444444; line-height: 1.7;\">If your answer is \u201cyes,\u201d your product is likely a Class III medicinal device containing medication, which falls under Rule 14 of the MDR. Standard technical file preparation may be insufficient for these devices. Under MDR 2017\/745, medical devices that deliver or administer a drug in a way that produces a systemic effect are classified as Class III under Rule 14 and are subject to both medical device and drug regulations.<\/p>\n<p style=\"font-size: 16px; color: #444444; line-height: 1.7;\">Era Management offers regulatory compliance strategy development, technical file preparation, and DMF (Drug Master File) support for your pharmaceutical medical devices.<\/p>\n\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div><\/div><\/div><div class=\"vc_row wpb_row vc_inner row vc_custom_1000001 vc_row-o-equal-height vc_row-flex\"><div class=\"vc_column_container col-md-6\"><div class=\"wpb_wrapper vc_column-inner\">\r\n\t<div class=\"wpb_text_column wpb_content_element wpb_custom_7c91d232724f73626cc933bd95b25ff0\" >\r\n\t\t<div class=\"wpb_wrapper\">\r\n\t\t\t<div style=\"background: #ffffff; padding: 30px; border-radius: 12px; box-shadow: 0 10px 30px rgba(0,0,0,0.05); border: 1px solid #f0f0f0; height: 100%;\">\n<h3 style=\"font-size: 22px; font-weight: bold; color: #0c3261; border-bottom: 2px solid #0088cc; padding-bottom: 8px; text-transform: uppercase; margin-bottom: 20px;\">Our Scope of Services<\/h3>\n<ul style=\"list-style: none; padding-left: 0; font-family: 'Poppins', sans-serif; font-size: 15px; color: #444444; line-height: 1.8; margin: 0;\">\n<li style=\"margin-bottom: 10px; display: flex; align-items: flex-start; gap: 10px;\"><span style=\"color: #0088cc; margin-top: 6px; flex-shrink: 0;\">\u203a<\/span>Product class verification under Rule 14 of Annex VIII of the MDR.<\/li>\n<li style=\"margin-bottom: 10px; display: flex; align-items: flex-start; gap: 10px;\"><span style=\"color: #0088cc; margin-top: 6px; flex-shrink: 0;\">\u203a<\/span>Establishing a regulatory strategy regarding drug content (MD\u2013MP borderline)<\/li>\n<li style=\"margin-bottom: 10px; display: flex; align-items: flex-start; gap: 10px;\"><span style=\"color: #0088cc; margin-top: 6px; flex-shrink: 0;\">\u203a<\/span>EMA or national authority consultation procedure support<\/li>\n<li style=\"margin-bottom: 10px; display: flex; align-items: flex-start; gap: 10px;\"><span style=\"color: #0088cc; margin-top: 6px; flex-shrink: 0;\">\u203a<\/span>Preparation of necessary pharmaceutical quality and safety data for the drug component.<\/li>\n<li style=\"margin-bottom: 10px; display: flex; align-items: flex-start; gap: 10px;\"><span style=\"color: #0088cc; margin-top: 6px; flex-shrink: 0;\">\u203a<\/span>Preparation or procurement of the DMF (Drug Master File)<\/li>\n<li style=\"margin-bottom: 10px; display: flex; align-items: flex-start; gap: 10px;\"><span style=\"color: #0088cc; margin-top: 6px; flex-shrink: 0;\">\u203a<\/span>Managing collaboration processes with the manufacturer\/supplier of the active substance.<\/li>\n<li style=\"margin-bottom: 10px; display: flex; align-items: flex-start; gap: 10px;\"><span style=\"color: #0088cc; margin-top: 6px; flex-shrink: 0;\">\u203a<\/span>Integration of drug-related sections into the technical file (Annexes II and III).<\/li>\n<li style=\"margin-bottom: 0; display: flex; align-items: flex-start; gap: 10px;\"><span style=\"color: #0088cc; margin-top: 6px; flex-shrink: 0;\">\u203a<\/span>Communication management with approved bodies and competent authorities.<\/li>\n<\/ul>\n<\/div>\n\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div><\/div><div class=\"vc_column_container col-md-6\"><div class=\"wpb_wrapper vc_column-inner\">\r\n\t<div class=\"wpb_text_column wpb_content_element wpb_custom_7c91d232724f73626cc933bd95b25ff0\" >\r\n\t\t<div class=\"wpb_wrapper\">\r\n\t\t\t<div style=\"background: #ffffff; padding: 30px; border-radius: 12px; box-shadow: 0 10px 30px rgba(0,0,0,0.05); border: 1px solid #f0f0f0; height: 100%;\">\n<h3 style=\"font-size: 22px; font-weight: bold; color: #0c3261; border-bottom: 2px solid #0088cc; padding-bottom: 8px; text-transform: uppercase; margin-bottom: 20px;\">DMF (Drug Master File) Support<\/h3>\n<p style=\"font-size: 15px; color: #444444; margin-bottom: 15px;\">For drug-containing devices, data on the quality and safety of the active ingredient must be presented in a DMF (or equivalent data pack). We:<\/p>\n<ul style=\"list-style: none; padding-left: 0; font-family: 'Poppins', sans-serif; font-size: 15px; color: #444444; line-height: 1.8; margin: 0;\">\n<li style=\"margin-bottom: 10px; display: flex; align-items: flex-start; gap: 10px;\"><span style=\"color: #0088cc; margin-top: 6px; flex-shrink: 0;\">\u2022<\/span>We enable the use of an existing DMF in the appropriate format.<\/li>\n<li style=\"margin-bottom: 10px; display: flex; align-items: flex-start; gap: 10px;\"><span style=\"color: #0088cc; margin-top: 6px; flex-shrink: 0;\">\u2022<\/span>If it&#039;s missing, we&#039;ll prepare a new DMF on your behalf or coordinate with the manufacturer.<\/li>\n<li style=\"margin-bottom: 0; display: flex; align-items: flex-start; gap: 10px;\"><span style=\"color: #0088cc; margin-top: 6px; flex-shrink: 0;\">\u2022<\/span>We manage confidential information sharing processes (LoA, restricted access partitions, etc.).<\/li>\n<\/ul>\n<h3 style=\"font-size: 20px; font-weight: bold; color: #0c3261; margin-top: 25px; margin-bottom: 15px;\">Why is this service important?<\/h3>\n<ul style=\"list-style: none; padding-left: 0; font-size: 15px; color: #444444; line-height: 1.6;\">\n<li style=\"margin-bottom: 8px;\">\u2022 Drug-assisted devices are classified in the highest risk category under the MDR.<\/li>\n<li style=\"margin-bottom: 8px;\">\u2022 The competent authority consultation process (Article 117) complicates the product approval process.<\/li>\n<li style=\"margin-bottom: 8px;\">\u2022 Delay in the approval process due to incorrect or incomplete filing.<\/li>\n<li style=\"margin-bottom: 0;\">\u2022 The difficulties of preparing a technical file without sufficient knowledge of pharmaceutical regulations.<\/li>\n<\/ul>\n<\/div>\n\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div><\/div><\/div><div class=\"vc_row wpb_row vc_inner row vc_custom_1000007 vc_row-o-equal-height vc_row-flex\"><div class=\"vc_column_container col-md-6\"><div class=\"wpb_wrapper vc_column-inner\">\r\n\t<div class=\"wpb_text_column wpb_content_element wpb_custom_7c91d232724f73626cc933bd95b25ff0\" >\r\n\t\t<div class=\"wpb_wrapper\">\r\n\t\t\t<div style=\"background-color: #f8f9fa; border-radius: 12px; padding: 30px; border-left: 5px solid #0088cc; box-shadow: 0 10px 30px rgba(0,0,0,0.05); height: 100%;\">\n<h3 style=\"font-size: 22px; font-weight: bold; color: #0c3261; margin-bottom: 20px; text-transform: uppercase;\">\u2705 Why Era Management?<\/h3>\n<div style=\"font-family: 'Poppins', sans-serif; font-size: 15px; color: #222222; font-weight: 600;\">\n<div style=\"margin-bottom: 10px; display: flex; align-items: center; gap: 10px;\"><span style=\"color: #0088cc;\">\u25cf<\/span>One of the rare consulting firms that takes a holistic approach to medical device and drug regulations.<\/div>\n<div style=\"margin-bottom: 10px; display: flex; align-items: center; gap: 10px;\"><span style=\"color: #0088cc;\">\u25cf<\/span>Expert team familiar with DMF structure and pharmaceutical data requirements.<\/div>\n<div style=\"margin-bottom: 10px; display: flex; align-items: center; gap: 10px;\"><span style=\"color: #0088cc;\">\u25cf<\/span>Strategic technical file management specific to CE certification processes.<\/div>\n<div style=\"margin-bottom: 0; display: flex; align-items: center; gap: 10px;\"><span style=\"color: #0088cc;\">\u25cf<\/span>Consultant team experienced in communication with approved bodies and authorities.<\/div>\n<\/div>\n<div style=\"margin-top: 25px; padding: 15px; background: #fff; border-radius: 8px; border: 1px dashed #0088cc;\">\n<h4 style=\"color: #0c3261; margin-top: 0;\">\ud83d\udcde Contact Us Now!<\/h4>\n<p style=\"margin-bottom: 5px;\">\u27a1 Does your product fall under Rule 14?<\/p>\n<p style=\"margin-bottom: 5px;\">\u27a1 Do you need to prepare for the consultation process?<\/p>\n<p style=\"margin-bottom: 0;\">\u27a1 What to do if there is no DMF? Consult with our experts to create a strategy tailored to your needs.<\/p>\n<\/div>\n<\/div>\n\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div><\/div><div class=\"vc_column_container col-md-6 vc_custom_1780480109934\"><div class=\"wpb_wrapper vc_column-inner\">\r\n\t<div class=\"wpb_single_image wpb_content_element vc_align_left wpb_content_element  vc_custom_1780480109934 wpb_custom_81a4f7ef9830bf958462581aa01150fb\"><div class=\"wpb_wrapper\">\r\n\t\t\t\r\n\t\t\t<div class=\"vc_single_image-wrapper vc_box_shadow_border  vc_box_border_grey\"><img loading=\"lazy\" decoding=\"async\" width=\"1920\" height=\"1280\" src=\"https:\/\/demo.erayonetim.com\/wp-content\/uploads\/era-yonetim-iso-01.jpg\" class=\"vc_single_image-img attachment-full\" alt=\"\" title=\"era-management-iso-01\" srcset=\"https:\/\/demo.erayonetim.com\/wp-content\/uploads\/era-yonetim-iso-01.jpg 1920w, https:\/\/demo.erayonetim.com\/wp-content\/uploads\/era-yonetim-iso-01-1024x683.jpg 1024w, https:\/\/demo.erayonetim.com\/wp-content\/uploads\/era-yonetim-iso-01-768x512.jpg 768w, https:\/\/demo.erayonetim.com\/wp-content\/uploads\/era-yonetim-iso-01-1536x1024.jpg 1536w, https:\/\/demo.erayonetim.com\/wp-content\/uploads\/era-yonetim-iso-01-640x427.jpg 640w, https:\/\/demo.erayonetim.com\/wp-content\/uploads\/era-yonetim-iso-01-400x267.jpg 400w, https:\/\/demo.erayonetim.com\/wp-content\/uploads\/era-yonetim-iso-01-367x245.jpg 367w\" sizes=\"auto, (max-width: 1920px) 100vw, 1920px\" \/><\/div>\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>En y\u00fcksek risk grubunda yer alan ila\u00e7l\u0131 t\u0131bbi cihazlar\u0131n klinik de\u011ferlendirmeleri, tasar\u0131m onay s\u00fcre\u00e7leri ve reg\u00fclasyonel dosyalamalar\u0131 i\u00e7in en \u00fcst seviyede teknik uzmanl\u0131k ve rehberlik sunuyoruz.<\/p>","protected":false},"featured_media":4295,"menu_order":0,"template":"","class_list":["post-3913","event","type-event","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/demo.erayonetim.com\/en\/wp-json\/wp\/v2\/event\/3913","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/demo.erayonetim.com\/en\/wp-json\/wp\/v2\/event"}],"about":[{"href":"https:\/\/demo.erayonetim.com\/en\/wp-json\/wp\/v2\/types\/event"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/demo.erayonetim.com\/en\/wp-json\/wp\/v2\/media\/4295"}],"wp:attachment":[{"href":"https:\/\/demo.erayonetim.com\/en\/wp-json\/wp\/v2\/media?parent=3913"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}